AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2011
Nov 8, 2011
30786_dirs_2011-11-08_799b1cca-3c0f-45ef-b1de-6d1289587c1d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2011-11-04
Reporting Person: GOETZ JOHN (Vice President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-04 | Restricted Stock Units | $0 | A | 1200 | Acquired | Bio-Rad A Common Stock (1200) | Direct | |
| 2011-11-04 | Non-Qualified Stock Option (right to buy) | $98.04 | A | 3500 | Acquired | 2021-11-04 | Bio-Rad A Common Stock (3500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 36200.4572 | Direct |
Footnotes
F1: Includes 91.3848 shares acquired under the Bio-Rad Laboratories employee stock purchase plan on September 30, 2011.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A Common Stock.
F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13